Bayamban, Ezekiel H.
HRN: 24-56-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2025
CEFUROXIME 1.5GM (VIAL)
01/04/2025
01/11/2025
IV
300mg
Q8h
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes